Viral gastroenteritis

Current Opinion in Infectious Diseases

Volumn 11, Issue 5, 1998, Pages 565-575

  Desselberger, Ulrich ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ACUTE GASTROENTERITIS; ADENOVIRUS; ASTROVIRUS; CALICIVIRUS; CORONAVIRUS; ENTEROVIRUS; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; PARVOVIRUS; REOVIRUS; REVIEW; ROTAVIRUS; TISSUE CULTURE; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0031770087     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199810000-00008     Document Type: Review

References (115)

1. Bern C, Martines J, de Zoysa I, Glass RI. The magnitude of the global problem of diarrhoeal disease: a ten year update. Bull WHO 1992; 70:705-714.
2. Blacklow NR, Greenberg HB. Viral gastroenteritis. N Engl J Med 1991; 325:252-264.
3. Murphy FA, Fanquet CM, Bishop DHL et al. (eds) Virus Taxonomy. Classification and Nomenclature of Viruses. New York: Springer Verlag, 1995.
4. Bhan MK, Mahalanabis D, Fontaine O, Pierce NF. Clinical trials of improved oral rehydration salt formulations: a review. Bull WHO 1994; 72:945-955.
5. Hart CA, Cunliffe NA. Viral gastroenteritis. Curr Opin Infect Dis 1997; 10:408-413. Last year's very informative, concise and balanced overview on viral gastroenteritis in this journal.
6. Estes MK. Rotaviruses and their replication. In: Fields Virology. Fields BN, Knipe DM, Howley PM et al. (editors): Philadelphia: Lippincott Raven; 1996; pp. 1625-1655. Excellent review on rotavirus particle and genome structure, strain classification and viral replication.
7. Offit PA, Clark HF, Blavat G, Greenberg HB. Reassortant rotaviruses containing structural proteins VP3 and VP7 from different parents induce antibodies protective against each parental serotype. J Virol 1986a; 60:491-496.
8. Offit PA, Shaw RD, Greenberg HB. Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J Virol 1986b; 58:700-703.
9. Green KY, Kapikian AZ. Identification of VP7 epitopes associated with protection against human rotavirus infection or shedding in volunteers. J Virol 1992; 66:548-553.
10. Garbarg-Chenon A, Bricout F, Nicolas JC. Serological characterization of human reassortant rotaviruses. J Virol 1986; 59:510-513.
11. Urasawa S, Urasawa T, Taniguchi K. Genetic reassortment between two human rotaviruses having different serotype and subgroup specificities. J Gen Virol 1986; 67:1551-1559.
12. Desselberger U. Reoviruses. In: Topley and Wilson's Microbiology and Microbial Infections. Collier L and Mahy B (editors): London: E Arnold: 1998a; pp. 537-550. A recent update on reovirology.
13. Phillips AD. Mechanisms of mucosal injury: human studies. In: Virus and the Gut. Farthing MJG (editor): London: Swan Press; 1989. pp. 30-40.
14. Burke B, Desselberger U. Rotavirus pathogenicity. Virology 1996; 218:299-305.
15. Broome RL, Vo PT, Ward RL, Clark HF, Greenberg HB. Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence. J Virol 1993; 67:2448-2455.
16. Hoshino Y, Saif L, Kang SY, Sereno MM, Chen WK, Kapikian AZ. Identification of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus in the gnotobiotic piglet model. Virology 1995; 209:274-280.
17. 2+ from the endoplasmic reticulum. J Virol 1995; 69:5763-5772.
18. Tian P, Hu Y, Schilling WP, Lindsay DA, Eiden J, Estes MK. The nonstructural glycoprotein of rotavirus affects intracellular calcium levels. J Virol 1994; 68:251-257.
19. Ball JM, Tian P, Zeng CQY, Morris AP, Estes MK. Age dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science 1996; 272:101-104.
20. Coulson BS, Grimwood K, Hudson IL, Barnes GL, Bishop RF. Role of antibody in clinical protection of children during reaction with rotavirus. J Clin Microbiol 1992; 30:1678-1684.
21. Feng N, Burns JW, Bracy L, Greenberg HB. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J Virol 1994; 68:7766-7773.
22. Velasquez FR, Matson DO, Calva JJ et al. Rotavirus infection in infants as protection against subsequent infection. N Engl J Med 1996; 355:1022-1028. Evidence that successive natural rotavirus infections protect increasingly from subsequent infections. Evidence for homo-and heterotypic infections.
23. •,25,26].
24. Ishida SI, Feng NG, Gilbert J, Tang BZ, Greenberg HB. Immune responses to individual rotavirus proteins following heterologous and homologous rotavirus infection in mice. J Infect Dis 1997; 175:1317-1323. Detailed record of the immune response in mice (serum IgG, gut IgA) to different rotavirus proteins following homologous and heterologous rotavirus infections.
25. Burns JW, Sindat-Pajouh M, Krishnaney AA, Greenberg HB. Protective effect of rotavirus VP6-specific IgA nomoclonal antibodies that lack neutralizing activity. Science 1996; 272:104-107.
26. Herrmann JE, Chen SC, Fynan EF, Santoro JC, Greenberg HB, Wang S, Robinson HL. Protection against rotavirus infections by DNA vaccination. J Infect Dis 1996; 174 (Suppl 1):S93-S97.
27. Gorziglia M, Green K, Nishkawa K, Taniguchi K, Jones R, Kapikian AZ, Chanock RM. Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol 1988; 62:2978-2984.
28. Gilger MA, Matson DO, Conner ME, Rosenblatt HM, Finegold MJ, Estes MK. Extraintestinal rotavirus infections in children with immunodeficiency. J Pediatr 1992; 120:912-917.
29. Gouvea V, Glass RI, Taniguchi K, Clark HF, Forrester B, Fang ZY. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990; 28:276-282.
30. Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992; 30:1365-1373.
31. Guarino A, Canani RB, Russo S, Albano F, Canani MB, Ruggeri FM et al. Oral immunoglobulins for treatment of acute rotaviral gastroenteritis. Pediatrics 1994; 93:12-16.
32. Kanfer EJ, Abrahamson G, Taylor J, Coleman JC, Samson DM. Severe rotavirus associated diarrhoea following bone marrow transplantation: treatment with oral immunoglobulin. Bone Marrow Transplant 1994; 14:651-652.
33. Beards GM, Desselberger U, Flewett TH. Temporal and geographical distribution of human rotavirus serotypes 1983-1988. J Clin Microbiol 1989; 27:2827-2833.
34. Noel JS, Beards GM, Cubitt WD. An epidemiological survey of human rotavirus serotypes and electropherotypes in young children admitted to two hospitals in North East London. J Clin Microbiol 1991; 29:2213-2219.
35. Gentsch JR, Woods PA, Ramachandran M, Das BK, Leite JP, Alfieri A et al. Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J Infect Dis 1996; 174 (Suppl 1):S30-S36. A review of the global distribution and combination of G and P types in natural isolates, also recording the emergence of strains of G types other than G1-G4 as the cause of human outbreaks. See references [38] and [39].
36. Brandt CD, Kim HW, Rodriguez WI, Arrobio JO, Jeffries BC, Stallings EP et al. Pediatric viral gastroenteritis during eight years of study. J Clin Microbiol 1983; 18:71-78.
37. Richardson S, Grimwood K, Gorrell R, Palombo E, Barnes G, Bishop R. Extended excretion of rotavirus after severe diarrhoea in young children. Lancet 1998; 351:1844-1848. Interesting observation of prolonged shedding of rotaviruses (for up to more than 50 days) after human infection with severe diarrhoea. Significance to be clarified as shedding was measured by ELISA and RT-PCR and mostly not confirmed by demonstration of infectious virus.
38. Gentsch J, Jin S, Parashar U, Woods P, Bresee J, Glass R. Human rotavirus P and G types in the United States. American Society for Virology Annual Meeting, Vancouver, 1998. American Society for Virology; Abstracts: W2-9, p 62. Evidence that G9 rotaviruses caused outbreaks of human gastroenteritis in several locations of the USA.
39. Ramachandran M, Gentsch J, Woods P, Glass R. Characterization of G9 rotaviruses. American Society for Virology Annual Meeting, Vancouver, 1998. American Society for Virology; Abstracts: W2-8, p62. A more detailed characterization of the human G9 US rotavirus isolates and evidence that they are most similar to recent African isolates.
40. Hung T. Rotavirus and adult diarrhoea. Adv Virus Res 1988; 35:193-218.
41. Matsumoto K, Hatano J, Kobayashi K, Hasegawa A, Yamazaki S, Nakata S et al. An outbreak of gastroenteritis associated with acute rotaviral infection in school children. J Infect Dis 1989; 160:611-615.
42. Caul EO, Ashley CR, Darville JM, Bridger JC. Group L rotavirus associated with fatal enteritis in a family outbreak. J Med Virol 1990; 30:201-205.
43. Jiang B, Dennehy PH, Spangenberger S, Gentsch JR, Glass RI. First detection of group C rotavirus in faecal specimens of children with diarrhea in the United States. J Infect Dis 1995; 172:45-50.
44. •].
45. • for the UK.
46. •].
47. Kapikian AZ. Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea in infants and young children: an introduction. In: Viral Infections of the Gastrointestinal Tract. 2nd ed. Kapikian AZ (editor). New York: Marcel Dekker Inc.; 1994; pp. 409-417.
48. Midthun K, Kapikian AZ. Rotavirus vaccines: an overview. Clin Microbiol Rev 1996; 9:423-434.
49. Desselberger U. Prospects for vaccines against rotaviruses. Rev Med Virol 1998b; 8:43-52. Recent review on approaches and prospects of rotavirus vaccines.
50. Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Evaluation Group. J Amer Med Ass 1995; 273:1191-1196.
51. Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines - report of the multicenter trial US rotavirus vaccine efficacy group. Pediatrics 1996; 97:7-14.
52. ••].
53. ••]
54. ••]
55. Conner ME, Zarley CD, Hu B, Parsons S, Drabinski D, Greiner S et al. Virus-like particles as a rotavirus subunit vaccine. J Infect Dis 1996; 174 (suppl 1):S88-S92.
56. Offit PA, Khoury CA, Moser CA, Clark HF, Kim JE, Speaker TJ. Enhancement of rotavirus immunogenicity by microencapsulation. Virology 1994; 203:134-143.
57. Krajden M, Brown M, Petrasek A, Middleton PJ. Clinical features of adenovirus enteritis: a review of 127 cases. Pediatr Infect Dis J 1990; 9:636-641.
58. Lew JF, Moe CL, Monroe SS, Allen JR, Harrison BM, Forrester BD et al. Astrovirus and adenovirus associated with diarrhoea in children in day care settings. J Infect Dis 1991; 164:673-678.
59. Cubitt WD. Caliciviruses. In: Viral Infections of the Gastrointestinal Tract. Kapikian AZ (editor). New York: Marcel Dekker; 1994; pp. 549-568.
60. Kapikian AZ, Estes MK, Chanock RM. Norwalk group of viruses. In: Fields Virology. Fields BN, Knipe DM, Howley PM et al. (editors). Philadelphia: Lippincott-Raven; 1996. pp. 783-810.
61. Jiang X, Wang M, Wang K, Estes MK. Sequence and genomic organization of Norwalk virus. Virology 1993; 195:51-61.
62. Lambden PR, Caul EO, Ashley CR, Clarke IN. Sequence and genome organization of a human small round-structured (Norwalk-like) virus. Science 1993; 259:516-518.
63. Matson DO, Zhong W, Nakata S, Numata K, Jiang X, Pickering LK. Molecular characterization of a human calicivirus with closer sequence relatedness to animalcaliciviruses than other known human caliciviruses. J Med Virol 1995; 45:215-222.
64. Liu BL, Clarke IN, Caul EO, Lambden PR. Human enteric caliciviruses have a unique genome structure and are distinct from the Norwalk-like viruses. Arch Virol 1995; 140:1345-1356.
65. Estes MK, Atmar RL, Hardy ME. Norwalk and related diarrhea viruses. In: Clinical Virology. Richman DD, Whitley RJ, Hayden FG (editors): New York: Churchill Livingstone; 1997. pp. 1073-1095. Excellent, up-to-date review on genome structure, classification, immunology and epidemiology of SRSVs.
66. Wang J, Jiang X, Madore HP et al. Sequence diversity of small round structured viruses. J Virol 1994; 68:5982-5990.
67. Moe CL, Gentsch J, Grohman G et al. Application of PCR to detect Norwalk virus in faecal specimens from outbreaks of gastroenteritis. J Clin Microbiol 1994; 32:642-648.
68. Ando T, Mulders MN, Lewis DC, Estes MK, Monroe SS, Glass RI. Comparison of the polymerase region of small round structured virus strains previously classified in three serotypes by solid-phase immune electron microscopy. Arch Virol 1994; 135:217-226.
69. Ando T, Monroe SS, Gentsch JR, Jin Q, Lewis DC, Glass RI. Detection and differentiation of antigenically distinct small round-structured viruses (Norwalk-like viruses) by reverse transcription-PCR and Southern hybridization. J Clin Microbiol 1995; 33:64-71.
70. Green J, Gallimore CI, Norcott JP, Lewis D, Brown DW. Broadly reactive reverse transcriptase poylmerase chain reaction in the diagnosis of SRSV-associated gastroenteritis. J Med Virol 1995; 47:392-398.
71. Lees DN, Henshilwood K, Green J, Gallimore CI, Brown DW. Detection of small round structured viruses in shellfish by reverse transcription - PCR. Appl Environ Microbiol 1995; 61:4418-4424.
72. Atmar RL, Neill FH, Woodley CM, Manger R, Fout GS, Burkhardt W et al. A collaborative evaluation of a method for the detection of Norwalk virus in shellfish tissue using the polymerase chain reaction. Appl Environ Microbiol 1996; 62:254-258.
73. Parrino TA, Schreiber TS, Trier JS, Kapikian AZ, Blacklow NR. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med 1977; 297:86-89.
74. Johnson PC, Mathewson JJ, Dupont HL, Greenberg HB. Multiple challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis 1990; 161:18-21.
75. Graham DY, Jiang X, Tanaka T, Opekun AR, Madore HP, Estes MK. Norwalk virus infection of volunteers: new insights based on improved assays. J Infect Dis 1994; 170:34-43.
76. Gray JJ, Cunliffe C, Ball J, Graham DY, Desselberger U, Estes MK. Detection of immunoglobulin M (IgM), IgA, and IgG Norwalk virus-specific antibodies by indirect enzyme-linked immunosorbent assay with baculovirus-expressed Norwalk virus capsid antigen in adult volunteers challenged with Norwalk virus. J Clin Microbiol 1994; 32:3059-3063.
77. Gray JJ, Jiang X, Morgan-Capner P, Desselberger U, Estes MK. Prevalence of antibodies to Norwalk virus in England: detection by enzyme-linked immunosorbent assay using baculovirus-expressed Norwalk virus capsid antigen. J Clin Microbiol 1993; 31:1022-1025.
78. Numata K, Nakata S, Jiang E, Estes MK, Chiba S. Epidemiological study of Norwalk virus infections in Japan and Southeast Asia by enzyme-linked immunosorbent assays with Norwalk virus capsid protein produced by the baculovirus expression system. J Clin Microbiol 1994; 32:121-126.
79. Hedberg CW, Osterholm MT. Outbreaks of food-borne and waterborne viral gastroenteritis. Clin Microbiol Rev 1993; 6:199-210.
80. Vinje J, Altena SA, Koopmans MPG. The incidence and genetic variability of small round structural viruses in outbreaks of gastroenteritis in The Netherlands. J Infect Dis 1997; 176:1374-1378. Recent update to show a high degree of diversity of SRSVs using molecular techniques.
81. Gray JJ, Green J, Cunliffe C, Gallimore CI, Lee JV, Neal K, Brown DWG. Mixed genogroup SRSV infections among a party of canoeists exposed to contaminated recreational water. J Med Virol 1997; 52:425-429. Interesting observation of infection of humans with different genotypes of SRSV originating from a common environmental source.
82. Caul EO. Small round structured viruses: airborne transmission and hospital control. Lancet 1994; 343:1240-1242.
83. Chrystie IL, Booth IW, Kidd AH, Marshall WC, Banatvala JE. Multiple faecal virus excretion in immunodeficiency. Lancet 1982; i:282.
84. Grohmann GS, Glass RI, Pereira HG, Monroe SS, Hightower AW, Weber R, Bryan RT. Enteric viruses and diarrhea in HIV-infected patients. N Engl J Med 1993; 329:14-20.
85. Jiang X, Wang M, Graham DY, Estes MK. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol 1992; 66:6527-6532.
86. Monroe SS, Jiang B, Stine SE, Koopmans M, Glass RI. Subgenomic RNA sequence of human astrovirus supports classification of Astroviridae as a new family of RNA viruses. J Virol 1993; 67:3611-3614.
87. Matsui SM, Lewis TL, Chiu E et al. An outbreak of astrovirus gastroenteritis in a nursing home and molecular characterization of the virus. Gastroenterlogy 1994; 106:A730.
88. Willcocks MM, Brown TDK, Madeley CR, Carter MJ. The complete sequence of a human astrovirus. J Gen Virol 1994; 75:1785-1788.
89. Noel JS, Lee TW, Kurtz JB, Glass RI, Glass RI. Typing of human astroviruses from clinical isolates by enzyme immunoassay and nucleotide sequencing. J Clin Microbiol 1995; 33:797-801.
90. Lee TW, Kurtz JB. Prevalence of astrovirus serotypes in the Oxford region 1976-92, with evidence for 2 new serotypes. Epidemiol Infect 1994; 112:187-193.
91. Koopmans MPG, Bijen MHL, Monroe SS, Vinje J. Astrovirus type-specific antibody prevalence in Utrecht, The Netherlands. American Society for Virology, 16. Annual Meeting, Bozeman/Montana. American Society for Virology; Abstracts, W35/1; 1997: p 158.
92. Lee T, Kurtz JB. Serial propagation of astrovirus in tissue culture with the aid of trypsin. J Gen Virol 1981; 57:421-424.
93. Matsui SM. Astrovirus. In: Topley and Wilson's Microbiology and Microbial Infections Collier L and Mahy B (editors): London: E Arnold1998. pp. 1111-1121. Excellent review, follow up [98].
94. Herrmann JE, Nowak NA, Perron-Henry DM, Hudson RW, Cubitt WD, Blacklow NR. Diagnosis of astrovirus gastroenteritis by antigen detection with monoclonal antibodies. J Infect Dis 1990; 161:226-229.
95. Herrmann JE, Blacklow NR, Matsui SM, Lewis TL, Estes MK, Ball JM, Brinker JP. Monoclonal antibodies for detection of Norwalk virus antigen in stools. J Clin Microbiol 1995; 33:2511-2514.
96. Clarke IN, Lambden PR, Caul RO. Human enteric RNA viruses: Caliciviruses and astroviruses. In: Topley and Wilson's Microbiology and Microbial Infections. Collier L and Mahy B (editors): London: E Arnold; 1998; pp. 511-535. Excellent, up-to-date review on SRSVs and astroviruses with emphasis on molecular biological data.
97. Oishi I, Yamazaki K, Kimoto T, Minekawa Y, Utagawa E, Yamazaki S et al. A large outbreak of acute gastroenteritis associated with astrovirus among students and teachers in Osaka, Japan. J Infect Dis 1994; 170:439-443.
98. Matsui SM, Greenberg HB. Astroviruses. In: Fields Virology. 3rd ed. Fields BN, Knipe DM, Howley PM et al. (editors): Philadelphia: Lippincott-Raven; 1996. pp. 811-824. Comprehensive review of the molecular biology, immunology and epidemiology of astroviruses.
99. Utagawa ET, Nishizawa S, Sekine S, Hayashi Y, Ishihara Y, Oishi I et al. Astrovirus as a cause of gastroenteritis in Japan. J Clin Microbiol 1994; 32:1841-1845.
100. Mitchell DK, Monroe SS, Jiang X, Maison DO, Glass RI, Pickering LK. Virologic features of an astrovirus diarrhea outbreak in a day care centre revealed by reverse transcription-polymerase chain reaction. J Infect Dis 1995; 172:1437-1444.
101. Melnick JL. Enteroviruses: Polioviruses, Coxsackieviruses, echoviruses, and newer enteroviruses. In: Fields Virology, 3rd ed.. Fields BN, Knipe DM, Howley PM et al. (editors): Philadelphia: Lippincott-Raven Publ; 1996. pp. 655-712.
102. Townsend TR, Bolyard EA, Yolken RH, Beschorner WE, Bishop CA, Burns WH et al. Outbreak of Coxsackie A1 gastroenteritis: a complication of bone marrow transplantation. Lancet 1982; i:820-823.
103. Patel JR, Daniel J, Mathan V. An epidemic of acute diarrhoea in rural Southern India associated with echovirus type 11 infection. J Hyg (Camb) 1985; 95:483-492.
104. Tyler KL, Fields BN. Reoviruses. In: Fields Virology, 3rd edition. Fields BN, Knipe DM, Howley PM et al. (eds.): Philadelphia: Lippincott Raven. 1996. pp. 1597-1623.
105. Vaucher YERay CG, Minnich LL, Payne CM, Beck D, Lowe P. Pleomorphic enveloped virus-like particles associated with gastrointestinal illness in neonates. J Infect Dis 1982; 145:27-36.
106. Chang C, Moscovici O, Lebon P, Rousset S. Association of coronavirus infection with neonatal necrotizing enterocolitis. Pediatrics 1982; 69:209-214.
107. Gerna G, Passarini N, Battaglia M, Rondanelli EG. Human enteric coronaviruses: antigenic relatedness to human coronavirus OC43 and possible etiologic role in viral gastroenteritis. J Infect Dis 1985; 151:796-803..
108. Marshall JA, Thompson WL, Gust ID. Coronavirus-like particles in adults in Melbourne, Australia. J Med Virol 1989; 29:238-243.
109. Koopmans M, Horzinek M. Toroviruses of animal and humans: a review. Adv Virus Res 1994; 43:233-273.
110. Koopmans MP, Goosen ES, Lima AA, McAuliffe IT, Nataro JP, Barrett LJ et al. Association of torovirus with acute and persistent diarrhoea in children. Pediatr Infect Dis J 1997; 16:504-507. Interesting data. However, the role of toroviruses as an obligatory human enteric pathogen remains controversial.
111. Levinson W, Bennets RW. Cytomegalovirus colitis in acquired immunodeficiency - a chronic disease with varying manifestations. Amer J Gastroenterol 1985; 80:445-447.
112. Nelson JA, Wiley CA, Reynolds-Kohler C, Reese CE, Margaretten W, Levy JA. Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet 1988; i:259-262.
113. Heise C, Daudekar S, Kumar P, Duplantier R, Donovan RM, Halsted CH. Human immunodeficiency virus infection of enterocytes and mononuclear cells in human jejunal mucosa. Gastroenterology 1991; 100:1521-1527.
114. Kotler DP, Reka SA, Borcich A, Cronin WJ. Detection, localization and quantitation of HIV-associated antigens in intestinal biopsies from patients with AIDS. Amer J Pathol 1991; 139:823-830.
115. Rabeneck L. AIDS enteropathy: What's in a name? J Clin Gastroenterol 1994; 19:154-157.